The Montreal Artificial Intelligence and Neuroscience ) conference will kick off on Sunday, December 9, with two days of lectures followed by a two-day programming workshop. Now in its second year, the gathering attracts researchers working at the intersection of AI and Neuroscience in dynamic and interconnected Montreal-based hubs. HBHL caught up with co-organizer Dr. Bratislav Misic, who leads an interdisciplinary research team at the Montreal Neurological Institute (MNI).
Genes run just about everything that happens in our bodies, including how proteins behave in the brain. Too little or too much of a particular protein can cause some of the most devastating neurological diseases and disorders.
Reducing stigma may address cognitive impairment in this population
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
Young scientists in the field of cognitive neuroscience got expert guidance and hands-on training in machine learning at a workshop organized by Healthy Brains for Healthy Lives (HBHL) and the ۲ݮƵ Centre for Integrative Neuroscience (MCIN), from October 15 to 17.
Lesson number one: Beware of the buzz.
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro), has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
When it comes to weight gain, the problem may be mostly in our heads, and our genes
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
A look at the latest ALS research and clinical care at The Neuro
Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS.
Memorandum of Understanding between the CIRM, the Agirre Lehendekaria Center and the Etxepare Basque Institute
For someone with Parkinson’s disease (PD), the simple desire to grasp a glass of water can become an insurmountable task, made impossible by the tremors in their hand or arm. Finding strategies to improve these movement impairments is one of the major goals of rehabilitating people with Parkinson’s disease.
At ۲ݮƵ University, Dr. Marc Roig, an assistant professor in the School of Physical and Occupational Therapy (SPOT), is studying the effects of using high-intensity exercise to stimulate the brain’s ability to learn and change with repeated experiences.
Partners agree to share resources, establish steering committee for closer collaboration
On April 20, 2018, Canadian, Chinese and Cuban neuroscience institutes strengthened an existing partnership with the signing of a memorandum of understanding in Chengdu, China.
Partners in the agreement include The Montreal Neurological Institute and Hospital (The Neuro) of ۲ݮƵ University, The Cuban Neuroscience Center, The University of Electronic Sciences and Technology of China, The West China Hospital, and The Tianfu New Area of Chengdu (TFNA).
The institute that developed the “Montreal Procedure” continues to be on the cutting edge
The Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the “Montreal Procedure,” which today is in use throughout the world. The Neuro became a pioneer in studying epilepsy through the use of electroencephalography (EEG) and magnetic resonance imaging (MRI).
The Healthy Brains for Healthy Lives (HBHL) initiative is happy to announce the launch of its Neuro-Innovation Fund. HBHL’s Neuro-Innovation Fund aims to close the gap between proof-of-concept research grants, and funding from traditional investors (angels, venture capitalist, institutional investors). The Fund will provide technology development grants to support further proof of principle and/or add value to new technologies or inventions related to the research themes of HBHL.
2017 Québec Science Discovery of the Year Award goes to the cancer-detection probe developed byKevin Petrecca and Frédéric Leblond
Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.
Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge
The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.